Target intelligence / Profile preview

Infected cell protein 4 (HSV-2) (ICP4)

Target
ICP4
Molecular classification
Transcription factor, Viral regulatory protein, DNA-binding protein
01

Overview

Infected cell protein 4 (ICP4) is a large (approximately 175 kDa) immediate early (alpha) protein encoded by the alpha 4 (UL54) gene of HSV-2. ICP4 is indispensable for viral replication; it binds to specific DNA promoter regions within the HSV genome and functions as the principal transcriptional regulator, essential for activating early (beta) and late (gamma) viral gene expression. ICP4 acts bidirectionally, promoting or repressing transcription depending on promoter and context. It is also extensively post-translationally modified and may possess GTP-binding activities. ICP4 is structurally and functionally conserved between HSV-1 and HSV-2, and is required for efficient lytic replication and for the virus to escape host cell antiviral responses. ICP4 has not been the direct target of any approved antiviral drug, but its central role makes it an ideal candidate for novel anti-herpesvirus therapeutic strategies.

Other names
ICP4Immediate early protein ICP4Alpha 4 proteinInfected cell polypeptide 4
02

Mechanism of action

Inhibition of viral transcription factor activity to block viral gene transcription and replication; Disruption of ICP4 binding to viral DNA promoters

03

Biological functions

Regulation of viral gene transcription (both activation and repression)Facilitation of transcriptional complex formation at HSV viral DNAEssential for the switch from immediate-early to early gene expression in HSV-2
04

Disease associations

Infection (central regulator in the replication of HSV-2 and HSV-1)May indirectly impact other infection-associated pathologies due to its essential role in HSV-2 lifecycle
05

Safety considerations

As an essential viral regulatory protein, targeting ICP4 could, in theory, generate selective pressure for resistance mutations.Therapies directed at viral regulatory proteins must not cross-react with human transcription factors to avoid toxicity.
06

Interacting drugs

No approved drugs that target ICP4 directly. However, ICP4 is a known target for antiviral drug discovery in herpesvirus research.

1 more in the full profile.

07

Biomarkers

ICP4 expression is a marker of lytic HSV-2 infection and is used in laboratory diagnostics to monitor active viral replication in infected cells

Beyond the preview

Go deeper on Infected cell protein 4 (HSV-2) (ICP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infected cell protein 4 (HSV-2) (ICP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call